1. Introduction {#s0005}
===============

Honey is composed of approximately 82.4% total carbohydrates (38.5% fructose, 31.0% glucose and 12.9% from carbohydrates consisting of maltose, sucrose and other sugars) ([@b0150], [@b0260]). The natural ingredients of honey show different activities against various microorganisms. Its activity is likely to be dependent on the grazing grounds and the weather conditions where the bees were raised, and on the natural structure of the blossom nectar ([@b0005]). Honey has an increasing effect on the levels of anti-oxidants, iron and rare elements in blood ([@b0250]).

[@b0005] showed that honey had a more pronounced inhibitory effect (85.7%) on Gram negative bacteria (*Pseudomonas aeruginosa*, Enterobacter spp., Klebsiella) in comparison to commonly used antimicrobial agents. A 100% inhibition was observed in the case of Gram positive methicillin-resistant *Staphylococcus aureus* in comparison to the use of antibiotics alone. A synergistic effect was achieved upon the application of honey together with the antimicrobial agents in both Gram negative and positive bacteria. [@b0045] reported the inhibitory effect of Manuka Honey on *Helicobacter pylori* growth. In addition, it was documented that honey could completely heal severe injuries ([@b0270]).

The use of honey as a drug for the treatment of disease dates back to 2100-2000 BC. For instance, pale honey was described by Aristotle (384-322 BC) as being "good for sore eyes and wounds" ([@b0180], [@b0260]). The antimicrobial properties of honey have been well documented, and honey has been used from ancient times as a method of accelerating wound healing. Its potential to assist wound healing has been demonstrated repeatedly ([@b0200], [@b0260]). A possible reason behind its activity relies on its ability to generate hydrogen peroxide by the bee-derived enzyme glucose oxidase ([@b0230], [@b0145]). Another possibility is the composition of honey, which has more than 181 constituents ([@b0090], [@b0125], [@b0180], [@b0260]).

Staphylococci bacteria are Gram-positive cocci ([@b0225]). The genus Staphylococcus is composed of 33 species ([@b0080]). Most staphylococci constitute the normal flora of the skin and mucus membranes ([@b0170]). Some are aerobic while others are anaerobic and can grow at high salt concentrations, reaching up to 10% ([@b0210]). The most pathogenic species is *S. aureus* ([@b0210]). Some coagulase-negative staphylococci (CNS) strains, causative agents of infection in immune-compromised individuals, developed resistance to antibiotics. These bacteria colonize devices that are implanted in the human body, such as nails, slides and industrial joints used in bones, heart valves and catheters of various types, as well as in peritoneal dialysis. It has been observed lately that there was an increase in the prevalence and incidence of methicillin resistant CNS and *S. aureus*, making it more challenging to treat such infections ([@b0155]). Coagulase-negative staphylococci are considered one of the most prevalent microorganisms that are involved in hospital-acquired infections ([@b0255]). Honey has been used to inhibit these bacteria as well as to prevent and treat skin and other infections ([@b0120]).

The aim of the study was to evaluate the effect of different types of honey including two local honey on both methicillin sensitive and resistant *S. aureus*.

2. Methodology {#s0010}
==============

2.1. Honey used {#s0015}
---------------

Five types of honey were used, namely Manuka Honey UMF +20 (SummerGlow Apiaries, New Zealand), Manuka Honey UMF +16 (SummerGlow Apiaries, New Zealand), Active +10 Manuka (Happy Valley Honey, New Zealand), *Nigella sativa* (Valley Honey, Kingdom of Saudi Arabia \[KSA\]), and Sidr (Valley Honey, KSA). The honey was kept in dark bottles away from sunlight. The age of the honey samples ranged from 6 to 10 months.

2.2. Physico-chemical properties {#s0020}
--------------------------------

pH, moisture and sugar contents were determined according to the International Honey Commission ([@b0085]). Total phenolic content was measured as reported in the literature according to [@b0265] and [@b0240].

2.3. Bacteria used {#s0025}
------------------

a.Methicillin sensitive *S. aureus* (MSSA): Ten strains of clinical isolates of MSSA were used. A control strain (ATCC MSSA) was also included (ATCC 29213, USA). The clinical isolates came from two different hospitals: King Abdulaziz Hospital, Jeddah, KSA and King Fahd Hospital, Jeddah, KSA.b.Methicillin resistant *S. aureus*: Ten strains of clinical isolates of MRSA were used. This is in addition to one ATCC MRSA (ATCC 26112, USA). The clinical isolates came from two different hospitals King Abdulaziz Hospital, Jeddah, KSA and King Fahd Hospital, Jeddah, KSA.

3. Study design {#s0030}
===============

Nutrient broth (NB) (Oxoid, U.K.) was used as a culture medium. Overnight cultures of both MSSA and MRSA were grown in NB. Bacterial strains were grown in the presence and absence (control) of different concentrations of honey. This was achieved by inoculating 0.1 ml of the overnight culture was inoculated into tubes containing 10 ml of NB and incubated overnight in the presence different concentrations of honey 0%, 10% (v/v), 20% (v/v) and 50% (v/v). Honey concentrations are expressed as percentage and weight at a density of 1.42 g/ml: 10% (v/v) (0.142 g/ml), 20% (v/v) (0.284 g/ml), and 50% (v/v) (0.701 g/ml).a.Nutrient broth: bacterial counts were then done by preparing serial dilutions and colonies were counted on NB agar. The percent decline was determined in comparison to the control.b.Agar: To evaluate the antimicrobial efficacy of honey using Mueller--Hinton Agar (HiMedia Laboratories, Mumbai, India), different concentrations of honey were added to molten warm agar (50--55 °C) to achieve the required concentration in the resulting Petri dishes which were used for the growth of the test bacteria. 0.1 ml of each one of the tested bacteria was inoculated onto those plates at 37 °C and incubated for 24 h and then counted.

3.1. Bactericidal/bacteriostatic effects of honey {#s0035}
-------------------------------------------------

In order to evaluate the bacteriostatic /bactericidal activity of honey, 50% (v/v) of each one of following types of honey: Manuka Honey UMF +20, Sidr honey and *N. sativa*, were dispensed into sterile tubes. 0.1 ml of each of the test bacterial strains was inoculated into those tubes and incubated for 24 h at 37 °C. This concentration resulted in the complete inhibition of bacterial growth. In order to verify whether the honey has a bacteriostatic/bactericidal, 1 ml was added to 9 ml broth without honey and incubated for 24, 48 and 72 h. 0.1 ml of those cultures was placed on nutrient agar (free of honey) for 24 h to check for signs of bacterial growth. the honey type was considered as bacteriostatic if growth occurred and bactericidal when inhibition of growth persisted.

3.2. Statistical analysis {#s0040}
-------------------------

One-way ANOVA was used to investigate whether there was a significant difference among the various experiments. The *t*-test was used to compare variables between MSSA and MRSA. *P*-values \<0.05 were considered significant.

4. Results {#s0045}
==========

4.1. Physico-chemical properties {#s0050}
--------------------------------

[Table 1](#t0005){ref-type="table"} shows the physico-chemical properties of the three different types of honey used (average ± standard deviation). The average densities (g/ml) for the honeys were as follows: 1.47 ± 0.04 (Manuka), 1.433 ± 0.01 (*N. sativa*) and 1.47 ± 0.01 (Sidr) and the differences were not significant among the different types used (*P* \< 0.05). The local Sidr honey was the least acidic with a mean pH value of 6.00 ± 0.02 and the differences were significant (*P*\< 0.05). There was also a significant difference in the mean sugar contents per 100 g of honey with values of 82.00 ± 0.58% (Manuka), 81.14% ± 0.95% (Sidr) and highest 92.05 ± 0.84 (*N. sativa*). Furthermore, the mean percentage moisture contents per 100 g of honey were 17.40% ± 0.00% (Manuka), 14.60% ± 0.58 (*Nigella stiva*) and 14.30% ± 0.58 (Sidr). Manuka Honey had a high total phenol content of 103.99 ± 1.68 mg GAEs/kg compared to 81.30 ± 0.02 mg GAEs/kg for *Nigella stiva* and 96.00 ± 0.02 mg GAEs/kg for Sidr. Regarding the phenol content the difference was significant among the three types of honey (*P*\< 0.05) with Manuka having the highest phenol content of 103.99 ± 1.68.Table 1Physicochemical parameters of honey samples used (average ± standard deviation, *n* = 3).ParametersManuka*Nigella sativa*SidrDensity (g/mL)1.47[a](#tblfn1){ref-type="table-fn"} ± 0.041.433[a](#tblfn1){ref-type="table-fn"} ± 0.011.47[a](#tblfn1){ref-type="table-fn"} ± 0.01Moisture %/100 g17.40[a](#tblfn1){ref-type="table-fn"} ± 0.0014.6[b](#tblfn1){ref-type="table-fn"} ± 0.5814.3[b,c](#tblfn1){ref-type="table-fn"} ± 0.58pH4.30[a,b](#tblfn1){ref-type="table-fn"} ± 0.044.43[b](#tblfn1){ref-type="table-fn"} ± 0.066.0[c](#tblfn1){ref-type="table-fn"} ± 0.20Sugar content %/100 g82.00[a,c](#tblfn1){ref-type="table-fn"} ± 0.5892.05[b](#tblfn1){ref-type="table-fn"} ± 0.8481.14[c](#tblfn1){ref-type="table-fn"} ± 0.95Total phenol (mg GAEs/kg)103.99[a](#tblfn1){ref-type="table-fn"} ± 1.6881.30[b](#tblfn1){ref-type="table-fn"} ± 0.0296.00[c](#tblfn1){ref-type="table-fn"} ± 0.02[^1][^2]

4.2. Effect of honey on MSSA and MRSA in broth and agar {#s0055}
-------------------------------------------------------

For all tested honey types, there was total inhibition of bacterial growth in both MSSA and MRSA at the highest concentration of 50% (v/v) ([Table 2](#t0010){ref-type="table"}). At a concentration of 10% (v/v), all three tested Manuka Honeys produced a significant decline in both MSSA and MRSA; *N. sativa* and Sidr honey did not cause a significant decrease in bacterial growth ([Table 2](#t0010){ref-type="table"}). A broader effect was evident when testing was done with honey at 20% (v/v) concentration. All types of honey caused a significant decline in bacterial growth for MSSA and MRSA. The same observation was noted when the agar method was used, except for MSSA with 20% (v/v) Sidr honey ([Table 3](#t0015){ref-type="table"}). Statistical analysis using the *t*-test analysis showed that there was no significant difference in the averages of the effect of different types of honey on each of the MSSA and MRSA strains (*P* = 0.480; [Table 4](#t0020){ref-type="table"}).Table 2Effect of different concentrations of honey on both methicillin sensitive and resistant *Staphylococcus aureus* using broth dilution method.ConcentrationBacteriaMean MSSA (CFU/ml)Mean MRSA (CFU/ml)10%(v/v)Control3.40 × 10^7^5.50 × 10^6^Manuka +103.70 × 10^3^[⁎](#tblfn2){ref-type="table-fn"}5.50 × 10^3^[⁎](#tblfn2){ref-type="table-fn"}Manuka +164.00 × 10^1^[⁎](#tblfn2){ref-type="table-fn"}5.05 × 10^2^[⁎](#tblfn2){ref-type="table-fn"}Manuka +200.33 × 10^1^[⁎](#tblfn2){ref-type="table-fn"}0.50 × 10^1^[⁎](#tblfn2){ref-type="table-fn"}*Nigella sativa*3.70 × 10^6^5.50 × 10^5^Sidr3.67 × 10^5^1.00 × 10^5^  20% (v/v)Manuka +104.00 × 10^1^[⁎](#tblfn2){ref-type="table-fn"}5.00 × 10^2^[⁎](#tblfn2){ref-type="table-fn"}Manuka +160.33 × 10^1^[⁎](#tblfn2){ref-type="table-fn"}5.00 × 10^2^[⁎](#tblfn2){ref-type="table-fn"}Manuka +200.00[⁎](#tblfn2){ref-type="table-fn"}0.00[⁎](#tblfn2){ref-type="table-fn"}*Nigella sativa*7.00 × 10^4^[⁎](#tblfn2){ref-type="table-fn"}5.50 × 10^4^Sidr3.67 × 10^4^[⁎](#tblfn2){ref-type="table-fn"}1.00 × 10^5^  50% (v/v)Manuka +100.00[⁎](#tblfn2){ref-type="table-fn"}0.00[⁎](#tblfn2){ref-type="table-fn"}Manuka +160.00[⁎](#tblfn2){ref-type="table-fn"}0.00[⁎](#tblfn2){ref-type="table-fn"}Manuka +200.00[⁎](#tblfn2){ref-type="table-fn"}0.00[⁎](#tblfn2){ref-type="table-fn"}*Nigella sativa*0.00[⁎](#tblfn2){ref-type="table-fn"}0.00[⁎](#tblfn2){ref-type="table-fn"}Sidr0.00[⁎](#tblfn2){ref-type="table-fn"}0.00[⁎](#tblfn2){ref-type="table-fn"}[^3][^4]Table 3Effect of different concentrations of honey on both methicillin sensitive and resistant *Staphylococcus aureus* using the agar dilution method.ConcentrationBacteriaMean MSSA (CFU/ml)Mean MRSA (CFU/ml)10% (v/v)Control2.03 × 10^8^3.90 × 10^8^Manuka + 103.75 × 10^4^[⁎](#tblfn3){ref-type="table-fn"}4.55 × 10^5^[⁎](#tblfn3){ref-type="table-fn"}Manuka + 164.19 × 10^4^[⁎](#tblfn3){ref-type="table-fn"}5.15 × 10^4^[⁎](#tblfn3){ref-type="table-fn"}Manuka + 202.10 × 10^2^[⁎](#tblfn3){ref-type="table-fn"}1.19 × 10^3^[⁎](#tblfn3){ref-type="table-fn"}*Nigella sativa*1.55 × 10^8^3.90 × 10^8^Sidr1.55 × 10^8^3.90 × 10^8^  20% (v/v)Manuka + 101.02 × 10^4^[⁎](#tblfn3){ref-type="table-fn"}1.00 × 10^1^[⁎](#tblfn3){ref-type="table-fn"}Manuka + 162.50 × 10^2^[⁎](#tblfn3){ref-type="table-fn"}0.00[⁎](#tblfn3){ref-type="table-fn"}Manuka + 201.00 × 10^1^[⁎](#tblfn3){ref-type="table-fn"}0.00[⁎](#tblfn3){ref-type="table-fn"}*Nigella sativa*7.27 × 10^4^[⁎](#tblfn3){ref-type="table-fn"}8.60 × 10^7^Sidr9.97 × 10^7^1.50 × 10^8^  50% (v/v)Manuka + 100.00[⁎](#tblfn3){ref-type="table-fn"}0.00[⁎](#tblfn3){ref-type="table-fn"}Manuka + 160.00[⁎](#tblfn3){ref-type="table-fn"}0.00[⁎](#tblfn3){ref-type="table-fn"}Manuka + 200.00[⁎](#tblfn3){ref-type="table-fn"}0.00[⁎](#tblfn3){ref-type="table-fn"}*Nigella sativa*0.00[⁎](#tblfn3){ref-type="table-fn"}0.00[⁎](#tblfn3){ref-type="table-fn"}Sidr0.00[⁎](#tblfn3){ref-type="table-fn"}0.00[⁎](#tblfn3){ref-type="table-fn"}[^5][^6]Table 4Comparison effect of honey on methicillin sensitive and resistant *Staphylococcus aureus.*Number of samplesMean (CFU/ml)Std. error mean*P*-valueMSSA1987.2082 × 10^6^1.62294 × 10^6^.480MRSA1988.9577 × 10^6^1.87161 × 10^6^[^7]

4.3. Bacteriostatic/bactericidal efficacy of honey {#s0060}
--------------------------------------------------

[Table 5](#t0025){ref-type="table"} demonstrates the inhibitory action of Manuka, *N. sativa*, and Sidr honey on the tested bacterial strains. Manuka Honey had a bactericidal effect, while the other two types of local honey possessed a bacteriostatic ability.Table 5Bacteriostatic/bactericidal effects of honey on methicillin sensitive and resistant *Staphylococcus aureus*.Bacterial strainsManuka +20*Nigellasativa*SidrMSSA (ATCC 29213)**−**++MRSA (ATCC 26112)**−**++MSSA[⁎](#tblfn4){ref-type="table-fn"}**−**++MRSA[⁎⁎](#tblfn5){ref-type="table-fn"}**−**++[^8][^9]

5. Discussion {#s0065}
=============

Published data indicate that natural honey consists mainly of carbohydrates (about 82%), water and other minor components. Those minor ingredients include: proteins, minerals, phytochemicals and antioxidants. It has been reported that those minor ingredients are the ones that are responsible for medical and biological activities of honey in the treatment of infections, burns, wounds and ulcers ([@b0205]). The honey sugars are mostly fructose (38.2%) and glucose (31.2%), sucrose concentration ranges between (0.7% and 1%), disaccharides (approximately 9%) some trisaccharides and higher saccharides ([@b0020]).

All the honey tested fell within the acceptable ranges concerning acceptable water contents between 13.66% and 25.35% ([@b0205]). Such levels are low to allow yeast fermentation as well as bacterial growth ([@b0095]). The high sugar content noted in Manuka and Sidr was comparable with *N. sativa* having a significantly higher sugar content among the three honeys. In the case of acidity, Manuka and *N. sativa* were comparable, while Sidr was the least acidic. The acidity is likely to contribute to the antibacterial potency of the honey ([@b0095]). In accordance with what has been published earlier, the data showed that Manuka Honey contained the highest amount of total phenolic compounds such as methyl syringate which provides this honey with its ability to scavenge potent superoxide free radicals and, thus, exerts its antibacterial activity ([@b0040], [@b0215]).

Different types of honey possess different efficacies and mechanisms against the same type of bacteria, with Manuka Honey showing the best performance. This is in accordance with what has been reported by other authors who used honey as an agent to inhibit biofilm formation by *S. aureus* ([@b0160]). Another study showed that at a concentration less than 10%, Manuka Honey was needed for the inhibition of all the 58 strains of Gram-positive MSSA and 18 strains of MRSA isolated from wounds ([@b0105], [@b0110]). The antibacterial effects of honey are not only due to its osmolarity, but also due to other important factors that are present in the composition of honey ([@b0100], [@b0110]). Such factors depend to a great extent on the bees' source of nectar, the location of the flowers and related weather conditions, the storage time and conditions, and the method of preservative treatment ([@b0055], [@b0200], [@b0235], [@b0180], [@b0060], [@b0145], [@b0260]). Consequently, the tested honey samples were kept in dark bottles away from sunlight and in a refrigerator ([@b0135]). The age of the honey samples ranged from 6 to 10 months. Moreover, honey contains several vitamins and minerals ([@b0025], [@b0260]). It also contains amino acids, antibiotic-rich proteins, phenol antioxidants, and other biologically active compounds ([@b0070], [@b0220], [@b0275], [@b0260]). Some types of honey also contain kynurenic acid, which may contribute to its antimicrobial properties ([@b0075], [@b0260]).

In this study, the type of honey and the concentration affected its bactericidal and bacteriostatic activities. This is in line with the report of other authors who found that honey was effective against antibiotic-resistant bacteria that colonize burn wounds, such as MRSA, vancomycin-resistant *Enterococcus* spp. (VRE) and multiple-resistant Gram-negative rods, including *P. aeruginosa*, *Acinetobacter* spp. and members of the Enterobacteriaceae family ([@b0130], [@b0065], [@b0260]). Studies have shown that Manuka Honey was effective against bacterial biofilms of Group A *Streptococcus pyogenes*, *Streptococcus mutans*, *Proteus mirabilis*, *P. aeruginosa*, *Enterobacter cloacae* and *S. aureus* ([@b0050], [@b0245], [@b0165], [@b0175]). Manuka Honey is produced from the nectar of the Manuka bush (*Leptospermum scoparium*), which is indigenous to New Zealand and Australia. Manuka exceptionally contains high concentrations of the anti-bacterial compound methylglyoxal, which may be the reason behind its high bactericidal activity. This non-peroxide antibacterial activity due to the presence of methylglyoxal is called the unique Manuka factor (UMF) ([@b0215]). However, the exact compound(s) that contribute to its activity have not yet been fully elucidated ([@b0195], [@b0015], [@b0135], [@b0260]).

Manuka Honey's antibacterial activity is not linked to hydrogen peroxide (H~2~O~2~) ([@b0135]). Therefore, the effect of this type of honey on microbes may be due to its low pH or high sugar content, or as mentioned previously. It was noted by [@b0135] that the efficacy of H~2~O~2~ based honey was compromised by temperature, while non-H~2~O~2~ based honey were not affected. This explains why the different types of honey may differ in their antimicrobial potential, depending on the time, storage, composition and source of nectar on which the reared bees were fed ([@b0135], [@b0180]). [@b0140] reported that Manuka Honey inhibited the growth MRSA by preventing cell division and potentiating oxacillin inhibition on MRSA.

Our results were in agreement with other published studies, showing that at a concentration of 50% (v/v) in a NB medium, Black Angenaz honey and Active Manuka Honey (AMH), Unique Manuka Factor (UMF) honey had an inhibitory effect against the fungus *Candida albicans*, *P. aeruginosa*, vancomycin resistant enterococci and MSSA ([@b0030]). The results indicated that UMF honey exerted a bactericidal effect on all microorganisms tested while AMH honey and Angenaz Black honey had only an inhibitory effect against all the tested bacteria, except for MSSA. [@b0190] also reported that honey was effective against both Gram-positive (*S. aureus*, *Bacillus subtilis*, *Bacillus cereus*, *Enterococcus faecalis*, and *Micrococcus luteus*) and Gram-negative bacteria (*Escherichia coli*, *P. aeruginosa*, and *Salmonella typhi*); this effect was either bacteriostatic or bactericidal. This is similar to the results obtained in this study, where sensitivity dependent on the type of honey and the concentration at which it was applied. It was reported that the inhibitory potential of Manuka Honey on MRSA appeared only at concentrations above 12.5% (v/v). In contrast, Ulmo 90 honey was bactericidal on MRSA at concentrations of 6.3% (v/v) and 3.1% (v/v). In the same study, Manuka Honey (particularly UMF +20) showed a high inhibitory effect on bacteria ([@b0235]).

[@b0035] performed a study in which they tested Malaysian honey on both MSSA and MRSA. They concluded that honey completely inhibited bacterial growth. In another study, [@b0185] showed that biofilms were abolished by the biocidal substances present in Norwegian honey, and the honey was good for wound care.

Up till now, there has been no report of bacterial resistance to honey. This is likely due to the complex composition of honey, which causes the individual components to act either individually or in synergy to prevent resistance ([@b0115]).

In conclusion, the efficacy of different types of honey against *S. aureus* was dependent on the type of honey and the concentration at which it was administered. Manuka Honey fortified with 20 UMF had highest bactericidal activity and proved to reduce the pattern of resistance of *S. aureus* compared to commonly used antibiotics. For the Islamic world, the potential use of honey has been documented in the Quran as a good source of treatment against many diseases. Future studies should focus on the use of local Saudi honey in combating antimicrobial resistance and as complementary to other antimicrobial dressings, since it is readily available in most parts of Middle East and relatively cheap, compared to mainline antibiotics, in addition to its use in the treatment of wounds, ulcers and cuts, since it has antibacterial activity and enhancing healing. Also, Future studies should pinpoint the functional components in a wide variety of local Saudi honeys and test their biological activities.
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[^1]: However, when a given parameter of a certain type of honey is indicated by the same letter, this means that there was no statistical significance (*P* \> 0.05).

[^2]: The subscripts a, b, and c represent which honeys are significantly different from one another.

[^3]: Abbreviations: MSSA: methicillin sensitive *Staphylococcus aureus*. MRSA: methicillin resistant *Staphylococcus aureus*.

[^4]: Differences between controls and the tested honeys were significant at the 0.05 level.

[^5]: Abbreviations: MSSA: methicillin sensitive *Staphylococcus aureus.* MRSA: methicillin resistant *Staphylococcus aureus.*

[^6]: Differences between controls and the tested honeys were significant at the 0.05 level.

[^7]: Abbreviations: MSSA: methicillin sensitive *Staphylococcus aureus.* MRSA: methicillin resistant *Staphylococcus aureus.*

[^8]: Clinical isolate of methicillin sensitive *Staphylococcus aureus.*

[^9]: Clinical isolate of methicillin resistant *Staphylococcus aureus.* (−) bactericidal effect, (+) bacteriostatic effect.
